E-LIB Suche - Ergebnisse für: Shand, David G.

1

Pharmacokinetics and biodistribution of RGD-targeted doxoru..:

Bibby, David C. ; Talmadge, James E. ; Dalal, Milind K....
International Journal of Pharmaceutics. 293 (2005) 1-2 - p. 281-290 , 2005

Link: https://doi.org/10.1016/..

2

Effect of Cetamolol on Epinephrine‐Induced Hypokalemia:

Klausner, Mark A. ; Irwin, Christopher ; Mullane, John F....
The Journal of Clinical Pharmacology. 28 (1988) 8 - p. 751-756 , 1988

Link: https://doi.org/10.1002/..

3

Human safety profile of tolrestat: An aldose reductase inhi..:

Ryder, Steven ; Sarokhan, Brenda ; Shand, David G..
Drug Development Research. 11 (1987) 2 - p. 131-143 , 1987

Link: https://doi.org/10.1002/..

4

In support of cardiac chronotropic beta2 adrenoceptors:

Brown, James E. ; McLeod, Andrew A. ; Shand, David G.
The American Journal of Cardiology. 57 (1986) 12 - p. F11-F16 , 1986

Link: https://doi.org/10.1016/..

5

The Effect of Etodolac Administration on Renal Function in ..:

Shand, David G. ; Epstein, Carol ; Kinberg‐Calhoun, Judy..
The Journal of Clinical Pharmacology. 26 (1986) 4 - p. 269-274 , 1986

Link: https://doi.org/10.1002/..

6

Hemodynamic and metabolic responses to exercise after alpha..:

McLeod, Andrew A. ; Brown, James E. ; Kitchell, Barbara B....
The American Journal of Medicine. 76 (1984) 2 - p. 97-100 , 1984

Link: https://doi.org/10.1016/..

7

Pharmacokinetic and pharmacodynamic effects of diltiazem:

Smith, Mark S. ; Verghese, Chacko P. ; Shand, David G..
The American Journal of Cardiology. 51 (1983) 8 - p. 1369-1374 , 1983

Link: https://doi.org/10.1016/..

8

Efficacy, safety, and pharmacokinetics of a concentration-m..:

Reiter, Michael J. ; Hammill, Stephen C. ; Shand, David G....
The American Journal of Cardiology. 52 (1983) 1 - p. 83-87 , 1983

Link: https://doi.org/10.1016/..

9

Propranolol Decreases Serum Thyroxine as Well as Triiodothy..:

JURNEY, THOMAS H. ; SMALLRIDGE, ROBERT C. ; ROUTLEDGE, PHILIP A...
Endocrinology. 112 (1983) 2 - p. 727-732 , 1983

Link: https://doi.org/10.1210/..

10

Effect of Verapamil on Left Ventricular Function at Rest an..:

D'Agostino Jr., Harry J. ; Pritchett, Edward L. C. ; Shand, David G..
Journal of Cardiovascular Pharmacology. 5 (1983) 5 - p. 812-817 , 1983

Link: https://doi.org/10.1097/..

11

Life-table methods for evaluating antiarrhythmic drug effic..:

Pritchett, Edward L.C. ; Hammill, Stephen C. ; Reiter, Michael J....
The American Journal of Cardiology. 52 (1983) 8 - p. 1007-1012 , 1983

Link: https://doi.org/10.1016/..

12

Lidocaine and Its Metabolites in Canine Plasma and Myocardi..:

Handel, Franklin ; Luzzi, Frank A. ; Wenger, Thomas L....
Journal of Cardiovascular Pharmacology. 5 (1983) 1 - p. 44-50 , 1983

Link: https://doi.org/10.1097/..

13

Comparison of high-dose and medium-dose propranolol in the ..:

Morris, Kenneth G. ; Higginbotham, Michael B. ; Coleman, R.Edward..
The American Journal of Cardiology. 52 (1983) 1 - p. 7-13 , 1983

Link: https://doi.org/10.1016/..

14

Is it safe to use intravenous verapamil to treat a patient ..:

Pritchett, Edward L.C ; Reiter, Michael J ; Hammill, Stephen C...
American Heart Journal. 105 (1983) 2 - p. 329-331 , 1983

Link: https://doi.org/10.1016/..

15

Pharmacokinetics of verapamil: Experience with a sustained ..:

Reiter, Michael J. ; Shand, David G. ; Aanonsen, Linda M....
The American Journal of Cardiology. 50 (1982) 4 - p. 716-721 , 1982

Link: https://doi.org/10.1016/..